CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial - Concepedia

Concepedia

Publication | Open Access

CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial

DOI Full Paper Access

119

Citations

36

References

2017

Year

Justin Stebbing, Y. Baranau, Valeriy Baryash, Alexey Manikhas, Vladimir Moiseyenko, Giorgi Dzagnidze, Edvard Zhavrid, Dmytro Boliukh, Daniil Stroyakovskii, Joanna Pikiel,

The Lancet Oncology

Breast OncologyHealth SciencesMedicineClinical TrialsBreast CancerEquivalence TrialCancer TreatmentOncologyRadiation OncologyReference TrastuzumabRadiologyHer2-positive Breast Cancer

References

	Year	Citations

Page 1

Page 1